|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global Cancer Statistics 2018: GLOBOCAN
Estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y: Epidemiology of esophageal
cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han-Ze Z, Guang-Fu J and Hong-Bing S:
Epidemiologic differences in esophageal cancer between Asian and
Western populations. Chin J Cancer. 31:281–286. 2012. View Article : Google Scholar
|
|
4
|
Lam AK: Introduction: Esophageal squamous
cell carcinoma-current status and future advances. Methods Mol
Biol. 2129:1–6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang W, Sun QK, He YF, Ma DC, Xie MR, Ji
CS and Hu B: Overexpression of periostin is significantly
correlated to the tumor angiogenesis and poor prognosis in patients
with esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
7:593–601. 2014.PubMed/NCBI
|
|
6
|
Underwood TJ, Hayden AL, Derouet M, Garcia
E, Noble F, White MJ, Thirdborough S, Mead A, Clemons N, Mellone M,
et al: Cancer-associated fibroblasts predict poor outcome and
promote periostin-dependent invasion in oesophageal adenocarcinoma.
J Pathol. 235:466–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rui W, Si L, Shutai Z, Min L and Zhu S:
Cellular and extracellular components in tumor microenvironment and
their application in early diagnosis of cancer. Anal Cell Pathol
(Amst). 2020:62837962020.
|
|
8
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna, Austria: 2014, http://www.R-project.org/February 10–2015
|
|
9
|
Palumbo A Jr, Meireles Da Costa N, Pontes
B, Leite de Oliveira F, Lohan Codeço M, Ribeiro Pinto LF and
Nasciutti LE: Esophageal cancer development: Crucial clues arising
from the extracellular matrix. Cells. 9:4552020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kashyap MK, Marimuthu A, Kishore CJ, Peri
S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P,
Sanjeeviah RC, et al: Genomewide mRNA profiling f esophageal
squamous cell carcinoma for identification of cancer biomarkers.
Cancer Biol Ther. 8:36–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sotoodehnejadnematalahi F and Burke B:
Structure, function and regulation of versican: The most abundant
type of proteoglycan in the extracellular matrix. Acta Med Iran.
51:740–750. 2013.PubMed/NCBI
|
|
12
|
Kang Y, Roife D, Lee Y, Lv H, Suzuki R,
Ling J, Rios Perez MV, Li X, Dai B, Pratt M, et al: Transforming
growth factor-β limits secretion of lumican by activated stellate
cells within primary pancreatic adenocarcinoma tumors. Clin Cancer
Res. 22:4934–4946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ween MP, Oehler MK and Ricciardelli C:
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
Int J Mol Sci. 12:1009–1029. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du WW, Yang W and Yee AJ: Roles of
versican in cancer biology-tumorigenesis, progression and
metastasis. Histol Histopathol. 28:701–713. 2013.PubMed/NCBI
|
|
15
|
Chida S, Okayama H, Noda M, Saito K,
Nakajima T, Aoto K, Hayase S, Momma T, Ohki S, Kono K and
Takenoshita S: Stromal VCAN expression as a potential prognostic
biomarker for disease recurrence in stage II–III colon cancer.
Carcinogenesis. 37:878–887. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang Q, Chen J, Zhang B, Niu J and He Y:
Prognostic significance of periostin and mammalian target of
rapamycin (mTOR) in locally advanced esophageal squamous cell
carcinoma. Med Sci Monit. 23:3200–3208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brierley JD, MK Gospodarowicz and
Wittekind C: The TNM Classification of Malignant Tumours. 8th
edition. Wiley-Blackwell; Hoboken, NJ, USA: pp. 2722016
|
|
18
|
Calon A, Lonardo E, Berenguer-Llergo A,
Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M,
Palomo-Ponce S, Tauriello DV, Byrom D, et al: Stromal gene
expression defines poor-prognosis subtypes in colorectal cancer.
Nat Genet. 47:320–329. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeung TL, Leung CS, Wong KK, Samimi G,
Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ and Mok SC: TGF-β
modulates ovarian cancer invasion by upregulating CAF-derived
versican in the tumor microenvironment. Cancer Res. 73:5016–5028.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gholamin M, Moaven O, Memar B, Farshchian
M, Naseh H, Malekzadeh R, Sotoudeh M, Rajabi-Mashhadi MT, Forghani
MN, Farrokhi F and Abbaszadegan MR: Overexpression and interactions
of interleukin-10, transforming growth factor beta, and vascular
endothelial growth factor in esophageal squamous cell carcinoma.
World J Surg. 33:1439–1445. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukai Y, Fukuchi M, Masuda N, Osawa H,
Kato H, Nakajima T and Kuwano H: Reduced expression of transforming
growth factor-beta receptors is an unfavorable prognostic factor in
human esophageal squamous cell carcinoma. Int J Cancer.
104:161–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pang L, Li Q, Wei C, Zou H, Li S, Cao W,
He J, Zhou Y, Ju X, Lan J, et al: TGF-β1/Smad signaling pathway
regulates epithelial-to-mesenchymal transition in esophageal
squamous cell carcinoma: In vitro and clinical analyses of cell
lines and nomadic Kazakh patients from northwest Xinjiang, China.
PLoS One. 9:e1123002014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo J, Chen XQ and Li P: The role of TGF-β
and its receptors in gastrointestinal cancers. Transl Oncol.
12:475–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asano K, Nelson CM, Nandadasa S,
Aramaki-Hattori N, Lindner DJ, Alban T, Inagaki J, Ohtsuki T,
Oohashi T, Apte SS and Hirohata S: Stromal versican regulates tumor
growth by promoting angiogenesis. Sci Rep. 7:172252017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ricciardelli C, Mayne K, Sykes PJ, Raymond
WA, McCaul K, Marshall VR and Horsfall DJ: Elevated levels of
versican but not decorin predict disease progression in early-stage
prostate cancer. Clin Cancer Res. 4:963–9371. 1998.PubMed/NCBI
|
|
26
|
Suwiwat S, Ricciardelli C, Tammi R, Tammi
M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD and
Horsfall DJ: Expression of extracellular matrix components
versican, chondroitin sulfate, tenascin, and hyaluronan, and their
association with disease outcome in node-negative breast cancer.
Clin Cancer Res. 10:2491–2498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kodama J, Hasengaowa, Kusumoto T, Seki N,
Matsuo T, Ojima Y, Nakamura K, Hongo A and Hiramatsu Y: Prognostic
significance of stromal versican expression in human endometrial
cancer. Ann Oncol. 18:269–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen XH, Lin WR, Xu MD, Qi P, Dong L,
Zhang QY, Ni SJ, Weng WW, Tan C, Huang D, et al: Prognostic
significance of Versican expression in gastric adenocarcinoma.
Oncogenesis. 4:e1782015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y and Du L: Role of pancreatic
stellate cells and periostin in pancreatic cancer progression.
Tumour Biol. 36:3171–3177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Zhang X, Yang Y, Yang S, Dong Z, Du
L, Wang L and Wang C: Periostin expression and its prognostic value
for colorectal cancer. Int J Mol Sci. 16:12108–12118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu M, Fejzo MS, Anderson L, Dering J,
Ginther C, Ramos L, Gasson JC, Karlan BY and Slamon DJ: Periostin
promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol.
119:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu SQ, Lv YE, Lin BH, Luo LM, Lv SL, Bi AH
and Jia YS: Silencing of periostin inhibits nicotine-mediated tumor
cell growth and epithelial-mesenchymal transition in lung cancer
cells. Mol Med Rep. 7:875–880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YJ, Kim IS, Park SA, Kim Y, Lee JE,
Noh DY, Kim KT, Ryu SH and Suh PG: Periostin-binding DNA aptamer
inhibits breast cancer growth and metastasis. Mol Ther.
21:1004–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim CJ, Sakamoto K, Tambe Y and Inoue H:
Opposite regulation of epithelial-to-mesenchymal transition and
cell invasiveness by periostin between prostate and bladder cancer
cells. Int J Oncol. 38:1759–1766. 2011.PubMed/NCBI
|
|
35
|
Liu AY, Zheng H and Ouyang G: Periostin, a
multifunctional matricellular protein in inflammatory and tumor
microenvironments. Matrix Biol. 37:150–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo JH, Zhou J and Gao Y: Correlation
between periostin and SNCG and esophageal cancer invasion,
infiltration and apoptosis. Asian Pac J Trop Med. 6:516–519. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Michaylira CZ, Wong GS, Miller CG,
Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim
SB, Herlyn M, et al: Periostin, a cell adhesion molecule,
facilitates invasion in the tumor microenvironment and annotates a
novel tumor-invasive signature in esophageal cancer. Cancer Res.
70:5281–5292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qin X, Yan M, Zhang J, Wang X, Shen Z, Lv
Z, Li Z, Wei W and Chen W: TGFβ3-mediated induction of Periostin
facilitates head and neck cancer growth and is associated with
metastasis. Sci Rep. 6:205872016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lv YJ, Wang W, Ji CS, Jia, Xie MR and Hu
B: Association between periostin and epithelial-mesenchymal
transition in esophageal squamous cell carcinoma and its clinical
significance. Oncol Lett. 14:376–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Troup S, Njue C, Kliewer EV, Parisien M,
Roskelley C, Chakravarti S, Roughley PJ, Murphy LC and Watson PH:
Reduced expression of the small leucine-rich proteoglycans,
lumican, and decorin is associated with poor outcome in
node-negative invasive breast cancer. Clin Cancer Res. 9:207–214.
2003.PubMed/NCBI
|
|
41
|
Leygue E, Snell L, Dotzlaw H, Hole K,
Hiller-Hitchcock T, Roughley PJ, Watson PH and Murphy LC:
Expression of lumican in human breast carcinoma. Cancer Res.
58:1348–1352. 1998.PubMed/NCBI
|
|
42
|
Ishiwata T, Cho K, Kawahara K, Yamamoto T,
Fujiwara Y, Uchida E, Tajiri T and Naito Z: Role of lumican in
cancer cells and adjacent stromal tissues in human pancreatic
cancer. Oncol Rep. 18:537–543. 2007.PubMed/NCBI
|
